Shandong New-line Biotech Co.

Shandong New Line Biotechnology Co., Ltd., in collaboration with Jiangsu Academy of Agricultural Sciences, and the International Bacteriophage Research Center, has established a Bacteriophage Industry Research Institute staffed by over 30 doctoral and master's degree holders. Through partnerships with Guangdong Academy of Agricultural Sciences, the Chinese Academy of Sciences, and other research institutions, the company is dedicated to developing bacteriophage-based solutions for various sectors, including livestock, aquaculture, agriculture, food, and medicine. This aligns with the national 14-department action plan to combat antimicrobial resistance.

The company has built extensive bacteriophage resources, including a collection of over 12,000 bacteriophage genomes, 4,000+ bacteriophage strains, and 50000+ pathogenic bacterial strains. It has also developed a large-scale production and purification technology system for bacteriophages, providing a strong foundation for the prevention and control of bacterial infections.

In the livestock industry, New Line's bacteriophage products have captured a significant market share, primarily used to control infections caused by E. coli, Salmonella, Clostridium perfringens, Staphylococcus aureus, and Riemerella anatipestifer, etc. The company has successfully addressed global challenges such as the control of Riemerella anatipestifer infections and Salmonella contamination, contributing to the reduction of antibiotic use in animal husbandry and ensuring the safety of meat, egg and dairy products.

In aquaculture, New Line has developed bacteriophages targeting highly pathogenic Vibrio species and combined them with microfluidic qPCR detection technology to provide rapid, accurate, and on-site diagnosis and control of diseases like AHPND, TPD, WFD, and Luminous vibriosis.